Relay Therapeutics has a promising 4D drug design platform but faces challenges with limited clinical data and high R&D expenses. Despite a strong IPO and substantial cash reserves, the stock has ...

Belite Bio's lead drug, Tinlarebant, targets eye diseases STGD1 and GA, showing promising results but with delayed phase 3 trial data expected by late 2024 or early 2025. Tinlarebant works by reducing ...

Talk about a bizarre feature of the human body: If you happened to swallow a razor blade, your stomach acid would dissolve it ...

Look almost anywhere in your home and you’ll likely find something made of silicone. Unfortunately, manufacturing silicone-based materials comes with a high environmental cost that is largely due to ...

Jupiter’s colossal storms generate lightning flashes at least 100 times more powerful than those on Earth, according to scientists analyzing data from NASA’s Juno spacecraft. The findings were ...

Remember when Japan sent a spacecraft to an asteroid 180 million miles away to scoop some dirt off the surface? Six years on from its arrival to Earth, that sample has yielded some insights about what ...

The biosynthesis of the great variety of natural plant products has not yet been elucidated for many medically interesting substances. In a new study, an international team of researchers was able to ...

We got to share in a rare moment of collective awe this week as four astronauts blasted off toward the moon, beginning a 10-day journey that will take them farther from Earth than any humans have ...

Natural history. Physics. Astronomy. Medicine. Math. Engineering. Climate science. Over its 50-year history, NOVA has presented discoveries and mind-blowing science phenomena in each of these ...